BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15180333)

  • 1. Analysis of pharmacokinetics, pharmacodynamics, and pharmacogenomics data sets using VizStruct, a novel multidimensional visualization technique.
    Bhasi K; Zhang L; Zhang A; Ramanathan M
    Pharm Res; 2004 May; 21(5):777-80. PubMed ID: 15180333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VizStruct: exploratory visualization for gene expression profiling.
    Zhang L; Zhang A; Ramanathan M
    Bioinformatics; 2004 Jan; 20(1):85-92. PubMed ID: 14693813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VizStruct for visualization of genome-wide SNP analyses.
    Bhasi K; Zhang L; Brazeau D; Zhang A; Ramanathan M
    Bioinformatics; 2006 Jul; 22(13):1569-76. PubMed ID: 16613906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Information-theoretic identification of predictive SNPs and supervised visualization of genome-wide association studies.
    Bhasi K; Zhang L; Brazeau D; Zhang A; Ramanathan M
    Nucleic Acids Res; 2006; 34(14):e101. PubMed ID: 16899448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maxsim2 - Real-time interactive simulations for computer-assisted teaching of pharmacokinetics and pharmacodynamics.
    Gabrielsson J; Andersson K; Tobin G; Ingvast-Larsson C; Jirstrand M
    Comput Methods Programs Biomed; 2014 Mar; 113(3):815-29. PubMed ID: 24461798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression databases--resources for pharmacogenomic R&D.
    Furness LM; Henrichwark S; Egerton M
    Pharmacogenomics; 2000 Aug; 1(3):281-8. PubMed ID: 11256579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized oxycodone dosing: using pharmacogenetic testing and clinical pharmacokinetics to reduce toxicity risk and increase effectiveness.
    Linares OA; Daly D; Linares AD; Stefanovski D; Boston RC
    Pain Med; 2014 May; 15(5):791-806. PubMed ID: 24517173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of the DruGeVar Database in Cancer Genomics and Pharmacogenomics.
    Sarris K; Komianou A; Patrinos GP; Katsila T
    Public Health Genomics; 2017; 20(2):142-147. PubMed ID: 28704821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping high-dimensional data onto a relative distance plane--an exact method for visualizing and characterizing high-dimensional patterns.
    Somorjai RL; Dolenko B; Demko A; Mandelzweig M; Nikulin AE; Baumgartner R; Pizzi NJ
    J Biomed Inform; 2004 Oct; 37(5):366-79. PubMed ID: 15488750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics.
    Chen ML
    Clin Pharmacokinet; 2006; 45(10):957-64. PubMed ID: 16984210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trials in pharmacogenetics and pharmacogenomics: methods and applications.
    Rioux PP
    Am J Health Syst Pharm; 2000 May; 57(9):887-98; quiz 899-901. PubMed ID: 10840530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pk-fit: a pharmacokinetic/pharmacodynamic and statistical data analysis software.
    Farenc C; Fabreguette JR; Bressolle F
    Comput Biomed Res; 2000 Oct; 33(5):315-29. PubMed ID: 11017724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using the time of maximum effect site concentration to combine pharmacokinetics and pharmacodynamics.
    Minto CF; Schnider TW; Gregg KM; Henthorn TK; Shafer SL
    Anesthesiology; 2003 Aug; 99(2):324-33. PubMed ID: 12883405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics for the Clinical Practitioner.
    Sleder AT; Kalus J; Lanfear DE
    J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):20-6. PubMed ID: 26054891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of SPLINDID, a semiparametric, model-based method for pharmacogenomic modeling of mRNA dynamics.
    Bhasi K; Forrest A; Ramanathan M
    Pharm Res; 2006 Apr; 23(4):663-9. PubMed ID: 16550471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative pharmacogenetics of nortriptyline: a novel approach.
    Kvist EE; Al-Shurbaji A; Dahl ML; Nordin C; Alván G; Ståhle L
    Clin Pharmacokinet; 2001; 40(11):869-77. PubMed ID: 11735606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Trends in the post-genomic pharmacological research].
    Wei EQ; Shen JZ
    Sheng Li Ke Xue Jin Zhan; 2002 Jan; 33(1):7-11. PubMed ID: 12001739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncology in vivo data integration for hypothesis generation.
    Wei J; Chen M
    J Integr Bioinform; 2012 Jul; 9(2):193. PubMed ID: 22773158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel.
    Zhang Y; Huo M; Zhou J; Xie S
    Comput Methods Programs Biomed; 2010 Sep; 99(3):306-14. PubMed ID: 20176408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP2D6 phenotype-specific codeine population pharmacokinetics.
    Linares OA; Fudin J; Schiesser WE; Daly Linares AL; Boston RC
    J Pain Palliat Care Pharmacother; 2015 Mar; 29(1):4-15. PubMed ID: 25562725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.